SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jeevan Scientific Technology informs about company updates

21 Dec 2016 Evaluate

Jeevan Scientific Technology has informed that the Company’s Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the ‘Office of Drug Control General, India (DCGI)’ on 16-December-2016 for a period of Three years. This Centre having four independent clinics having a total capacity of 132 beds will facilitate end-to-end Bioequivalence studies by Jeevan Scientific Technology.

The above information is a part of company’s filings submitted to BSE.

Jeevan Scientific Share Price

79.69 -0.86 (-1.07%)
15-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 2161.70
Infosys 1135.20
HCL Tech. 1119.15
Wipro 181.40
Tech Mahindra 1425.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: